Trials / Completed
CompletedNCT02389530
Use of Fluorescein Dye for the Removal of Brain Tumors
- Status
- Completed
- Phase
- —
- Study type
- Observational
- Enrollment
- 91 (actual)
- Sponsor
- University of Pittsburgh · Academic / Other
- Sex
- All
- Age
- 18 Years
- Healthy volunteers
- Not accepted
Summary
Fluorescein is a dye agent that can be injected through an intravenous line. It has been shown to help tell the difference between brain tumor tissue and normal brain tissue when it is used together with a specialized filter on a microscope in the operating room. The investigators plan to study the use of fluorescein in the removal of brain tumors at a low dose.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| DRUG | Fluorescein | Fluorescein will be administered intravenously at a dose between 250 mg and 400 mg in the experimental arm. |
Timeline
- Start date
- 2015-05-01
- Primary completion
- 2018-06-01
- Completion
- 2018-06-01
- First posted
- 2015-03-17
- Last updated
- 2018-08-03
Locations
1 site across 1 country: United States
Source: ClinicalTrials.gov record NCT02389530. Inclusion in this directory is not an endorsement.